Physician profile
Shannon E Murphy
NPI 1285050278
$598.14
in general payments reported to CMS, 2019-2025
19 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $106 · 2022: $111 · 2023: $79.25 · 2024: $171 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $380.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $76.67 | 2022-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $75.45 | 2021-2024 | |
| Lilly USA, LLC | $53.20 | 2021 | |
| Pfizer INC. | $44.49 | 2021-2024 | |
| Astellas Pharma US INC | $39.83 | 2023-2025 | Veozah |
| Organon LLC | $37.49 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $32.38 | 2023 | Farxiga |
| Axsome Therapeutics, INC. | $31.47 | 2023-2024 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $27.90 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $27.30 | 2025 | Caplyta |
| Biohaven Pharmaceutical Holding Company Ltd. | $23.77 | 2022 | |
| Merck Sharp & Dohme LLC | $20.03 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.78 | 2024 | |
| Janssen Pharmaceuticals, INC | $16.59 | 2024 | Spravato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.48 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15.42 | 2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $15.20 | 2023 | Trelegy Ellipta |
| Neurocrine Biosciences, INC. | $13.91 | 2024 | Ingrezza |
| Aimmune Therapeutics, INC. | $13.78 | 2025 | Zenpep |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.